News
The winners of IBIS Capital’s 2024 HealthTechX Awards were revealed on stage at the HealthTechX Summit on 28th February. Celebrating innovation, impact and growth, the awards recognise companies that are using technology to advance …
April 3, 2024
In the wake of the toughest funding market in 5 years, IBIS Capital CEO, Charles McIntyre anticipates a cautious recovery in 2024 demanding optimism amid geopolitical uncertainties. Plus, market roundups & industry analyses across …
April 3, 2024
Dr Michelle Tempest and Marc Kitten, both Partners at healthcare and life sciences consultancy Candesic, explore the excitement around Digital therapeutics (DTx) as an emerging field in healthcare. DTx use technology to deliver evidence-based …
April 3, 2024
Coverage on STEM education for sustainability and trends that have redefined the healthtech investment landscape. Plus, AI in clinical trial protocol design, the future beyond conventional AI, market roundups & industry analyses across EdTech …
September 30, 2023
A roundup of the 2023 EdTechX Summit, and a venture capital perspective on AI in Healthcare. Plus, news on the EdTechX Award Winners, how a gynaecological health platform is tackling the gender pain and diagnostics gap, market roundups …
June 30, 2023
Valentina Milanova, Founder of Daye, joins IBIS Capital Vice President, Bracy Fertig, in an enlightening conversation about her mission to bridge the gender gap in medical research and innovation, specifically for gender pain and …
May 23, 2023
Regulated by the Financial Conduct Authority.
Copyright © 2022 IBIS Capital Limited. All Rights Reserved.